United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 389,200 | 464,700 | 445,500 | 444,600 | 370,500 |
| Cost of Goods | 53,200 | 53,000 | 19,500 | 18,900 | 14,300 |
| Gross Profit | 336,000 | 411,700 | 426,000 | 425,700 | 356,200 |
| Operating Expenses | 29,300 | 272,700 | 102,700 | 338,100 | 92,900 |
| Operating Income | 306,900 | 139,000 | 323,800 | 88,500 | 263,600 |
| Interest Expense | 2,600 | 3,500 | 3,300 | 1,400 | 800 |
| Other Income | 4,700 | 5,500 | 200 | -42,900 | 800 |
| Pre-tax Income | 309,000 | 141,000 | 320,700 | 44,200 | 263,600 |
| Income Tax | 64,500 | 122,000 | 44,400 | 100,200 | 85,000 |
| Net Income Continuous | 244,500 | 19,000 | 276,300 | -56,000 | 178,600 |
| Net Income | $244,500 | $19,000 | $276,300 | $-56,000 | $178,600 |
| EPS Basic Total Ops | 5.65 | 0.37 | 6.37 | -1.25 | 4.01 |
| EPS Basic Continuous Ops | 5.65 | 0.37 | 6.37 | -1.25 | 4.01 |
| EPS Diluted Total Ops | 5.57 | 0.40 | 6.27 | -1.25 | 3.89 |
| EPS Diluted Continuous Ops | 5.57 | 0.40 | 6.27 | -1.25 | 3.89 |
| EBITDA(a) | $314,800 | $146,700 | $331,500 | $96,200 | $271,500 |